FDA Clearance Tracker · P000058-S060
INFUSE BONE GRAFT/Medtronic Interbody FUSION DEVICE
Last checked: Nov 20, 2026Latest source record: Sep 16, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Sep 16, 2016
Approved
Time to decision
87 days
Received Jun 21, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000058-S060
- Device name
- INFUSE BONE GRAFT/Medtronic Interbody FUSION DEVICE
- Applicant
- Medtronic Sofamor Danek USA, Inc.
- Applicant location
- Memphis, TN
- Received
- Jun 21, 2016
- Decided
- Sep 16, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P000058
Device type
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
Approval for increasing the size of the bioreactor used to manufacture rhBMP-2 from 6000 L to 12,000 L at the Pfizer Andover, MA Facility.
Source documents
Other decisions for Medtronic Sofamor Danek USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262572 · Decided Oct 29, 2026 · 94 days after receipt
Device type: Intervertebral Fusion Device With Bone Graft, Lumbar (MAX) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.